Plus Therapeutics regains Nasdaq minimum equity compliance after private placement

PLUS THERAPEUTICS, INC.

Received Nasdaq letter dated March 7, 2025 confirming compliance with minimum stockholders' equity requirement (Rule 5550(b)(1)).
Compliance achieved via private placement disclosed on March 4, 2025; escrow funds now released to the company.
Subject to Mandatory Panel Monitor until March 7, 2026; any future non-compliance triggers immediate delisting without cure period.

item 8.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-050390
form_type: 8-K
ticker: PSTV
cik: 0001095981
company_name: PLUS THERAPEUTICS, INC.
filed_at: 2025-03-10T23:59:59+00:00
discovered_at: 2026-05-14T18:03:02.919359+00:00
generated_at: 2026-05-25T00:48:49.465918+00:00
sec_items: ["8.01"]
event_type: regulatory
sentiment: positive
materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-050390
json_url: https://secwatch.observer/filing/0001193125-25-050390.json
markdown_url: https://secwatch.observer/filing/0001193125-25-050390.md
text_url: https://secwatch.observer/filing/0001193125-25-050390.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312525050390/0001193125-25-050390-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312525050390/d938890d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-050390

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.